PubMed
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline
Molitch et al., 2011
Hormonal & EndocrineFDA Approved (indication-specific)S
HGH (Somatropin)
Human Growth Hormone / rhGH
Human Growth Hormone (somatropin, rhGH) is a recombinant form of endogenous growth hormone used clinically for growth hormone deficiency and selected catabolic conditions. It remains one of the most studied anabolic endocrine therapies, with extensive evidence in pediatric and adult GHD populations and ongoing registry data for long-term outcomes. Off-label use for body composition and anti-aging remains medically controversial and should be physician-supervised.
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
- Studies cited
- 3
- Research grade
- S
- Community score
- 128
- Trackers
- 2,561
Trend index
Overview
About HGH (Somatropin)
Human Growth Hormone (somatropin, rhGH) is a recombinant form of endogenous growth hormone used clinically for growth hormone deficiency and selected catabolic conditions. It remains one of the most studied anabolic endocrine therapies, with extensive evidence in pediatric and adult GHD populations and ongoing registry data for long-term outcomes. Off-label use for body composition and anti-aging remains medically controversial and should be physician-supervised.
- Category
- Hormonal & Endocrine
- Regulatory status
- FDA Approved (indication-specific)
- Also known as
- Human Growth Hormone / rhGH
- Self-reports
- 28
Community
What 28 users report
28 community reports
Positive 2% · Neutral 98% · Negative 0%
Most reported benefits
Appetite
167
Recovery
167
Most reported side effects
Water retention
164
Dose distribution
Median: 0–25 mcg · Most common: 0–25 mcg
0–25
144
25–50
0
50–100
0
100–200
0
200–400
0
400–600
0
600–1000
6
1000–2000
0
2000+
17
Commonly stacked with
How repeat users are trending
Among repeat reporters, 88% said they felt similar to their last entry, 12% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 133 days · Based on 26 repeat reporters
Research
Cited research (1)
Source
Help
Frequently asked
What do PeptIQ users report about HGH (Somatropin)?
This page summarizes 28 anonymized self-reports from PeptIQ users who track HGH (Somatropin), including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
What research is cited for HGH (Somatropin)?
1 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
Is HGH (Somatropin) safe to use?
This wiki does not assess safety or recommend use. HGH (Somatropin) is listed as FDA Approved (indication-specific). Consult a licensed clinician for personal medical decisions.
What are the purported benefits and uses of HGH (Somatropin)?
Research, primarily in animal models, suggests HGH (Somatropin) may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.
SourceWhat is the legal status of HGH (Somatropin)?
HGH (Somatropin) is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified HGH (Somatropin) as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.
SourceWhat are the known or theoretical side effects and risks of HGH (Somatropin)?
The safety and effectiveness of HGH (Somatropin) have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.
SourceWhat is the current state of research on HGH (Somatropin)?
While there are over 200 published studies on HGH (Somatropin), the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.
Source